Takara Bio USA, Inc. – Develops, manufactures, and distributes pharmaceutical products
- Company: Takara Bio USA, Inc.
- Street: 1290 Terra Bella Ave.
- City/Town/Village: Mountain View
- State/Prefecture: California
- Country: United States
- Zip/Postal Code: 94043
- Phone: (650) 919-7300
- Website: http://www.clontech.com/
- Contact: OrdersUS@takarabio.com
- Listed: 02/15/2018 10:44 am
- Expires: 236 days, 19 hours
Takara Bio USA, Inc. (formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of kits, reagents, and instruments for life science research under the Takara®, Clontech®, and Cellartis® brands. Takara Bio USA is part of a company that holds a leadership position in the global market and is committed to improving the human condition through biotechnology. Our mission is to develop high-quality innovative tools and services to accelerate discovery.
Key products include SMARTer® NGS kits; SMARTer™ and SmartChip™ automation systems; high-performance qPCR and PCR reagents (including Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cell services, culture systems, cell lines, and reagents; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; Capturem™ protein purification solutions; and Living Colors® fluorescent proteins.
These and other products support applications including studies of gene regulation and function by a variety of methods including NGS; analyses of protein interaction, localization, and activity; drug discovery research and toxicity testing; development of clinical diagnostic assays; plant and food research; and stem cell research.
Takara Bio USA Showcase New Open-Platform Single-Cell Automation System at AGBT 2018
Date: Feb. 12, 2018
MOUNTAIN VIEW, Calif., Feb. 12, 2018 – To advance the understanding of cell diversity and how that diversity impacts complex cellular functions including interactions with other cells and molecules, growth, and disease states, Takara Bio USA, Inc., (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce the launch of the SMARTer™ ICELL8® cx System. The system will be presented to the scientific community at the Advances in Genome Biology and Technology (AGBT) General Meeting in Orlando FL, February 12–15, 2018.
Continue reading »